Welcome to a new episode […]

Liraglutide hit the headlines in January because it had just been approved by the European Medicines Agency (EMA) for the treatment of obesity, to be marketed as “Saxenda”. The EMA had previously approved it for type 2 diabetes in July 2009. In America the approval for obesity had come a month earlier in December 2014.

Developing a safe and effective […]

Here are some heretical thoughts about the war against cancer.
“It’s unwinnable. We not going to cure it and we don’t need to.”
“Everyone thinks being diagnosed with cancer is a calamity. It’s not necessarily the case. We can transform cancer from a dreaded killer to something we can live with.”

 Like the proverbial bus service, […]

Professor Mina Bissell presents a fascinating challenge to the cancer establishment. She is a highly respected academic and leading authority on breast cancer at the University of California, where she is Distinguished Scientist with Lawrence Berkeley National Laboratory’s Life Sciences Division next to UCB campus.

There is a major flaw […]

Over the past year I have been wondering whether there is something deeply flawed about research into the effects of high fat diets on rats and mice, done presumably to clarify the effects on humans. The rodent work consistently tells us that high fat diets make you fat and diabetic, while research on humans finds they do the opposite. What is going on?

Have you ever noticed that […]

Last month two new cholesterol lowering drugs stepped into the limelight at AHA’s (American Heart Association) annual conference. Neither is likely to make it to market until the end of next year but soon after that they are likely to be coming to a doctor’s surgery near you.